This year's winners offer slices of innovation.
Regeneron drug boosts survival of Ebola to 90%
New study shows that a pair of experimental treatments could increase the chances of surviving Ebola.
Michael McClellan is leaving his CFO post for personal reasons.
The drugmaker has received a Form 483 with six observations from the U.S. FDA.
Jack Bailey, President U.S. Pharmaceuticals, has decided to step down from his role at the end of the year.
Don't miss your Daily Dose. Get news like this delivered right to your inbox.